Flex (FLEX) had the highest return between December 20, 2023 and January 4, 2024 by a large-cap US stock, returning 69.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Flex (FLEX) | 12/20/2023 - 1/4/2024 | 69.9% |
Moderna (MRNA) | 12/20/2023 - 1/4/2024 | 22.19% |
Rocket Lab USA (RKLB) | 12/20/2023 - 1/4/2024 | 16.88% |
ANSYS (ANSS) | 12/20/2023 - 1/4/2024 | 15.59% |
Trip Group Ltd ADR (TCOM) | 12/20/2023 - 1/4/2024 | 13.62% |
argenx NV ADR (ARGX) | 12/20/2023 - 1/4/2024 | 12.47% |
MicroStrategy (MSTR) | 12/20/2023 - 1/4/2024 | 11.2% |
Viatris (VTRS) | 12/20/2023 - 1/4/2024 | 10.84% |
Neurocrine Biosciences (NBIX) | 12/20/2023 - 1/4/2024 | 10.5% |
TFI International (TFII) | 12/20/2023 - 1/4/2024 | 9.54% |
Merck (MRK) | 12/20/2023 - 1/4/2024 | 9.21% |
Amgen (AMGN) | 12/20/2023 - 1/4/2024 | 9.12% |
Allstate (ALL) | 12/20/2023 - 1/4/2024 | 8.02% |
Novartis AG ADR (NVS) | 12/20/2023 - 1/4/2024 | 7.57% |
Incyte (INCY) | 12/20/2023 - 1/4/2024 | 7.4% |
Kellanova (K) | 12/20/2023 - 1/4/2024 | 7.35% |
Regeneron Pharmaceuticals (REGN) | 12/20/2023 - 1/4/2024 | 7.31% |
LPL Financial (LPLA) | 12/20/2023 - 1/4/2024 | 6.76% |
GlaxoSmithKline PLC ADR (GSK) | 12/20/2023 - 1/4/2024 | 6.66% |
Eli Lilly and (LLY) | 12/20/2023 - 1/4/2024 | 6.6% |
Kinsale Capital (KNSL) | 12/20/2023 - 1/4/2024 | 6.36% |
Novo Nordisk A-S (NVO) | 12/20/2023 - 1/4/2024 | 6.35% |
Citigroup (C) | 12/20/2023 - 1/4/2024 | 6.06% |
Gilead Sciences (GILD) | 12/20/2023 - 1/4/2024 | 6.05% |
Pilgrims Pride (PPC) | 12/20/2023 - 1/4/2024 | 5.86% |
Large-cap stocks are treated as having a market cap of $10B+.
